Develops treatments for central nervous system movement and fluency disorders like stuttering and Tourette syndrome in children and adolescents.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Emalex Biosciences is a biopharmaceutical company focused on developing treatments for central nervous system movement disorders and fluency disorders with limited or no treatment options. Aligned with its mission, the company is evaluating treatments for childhood-onset fluency disorder(stuttering), and for children and adolescents with Tourette syndrome.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Investors
Bain Capital
Fidelity Management and Research Co.
Paragon Biosciences
Valor Equity Partners
Emalex Biosciences Valuations & Financials
View real-time NPM data on Emalex Biosciences stock including daily Emalex Biosciences stock price estimates, valuation history, and historical share price information. Access Emalex Biosciences financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Emalex Biosciences pricing across six independent market signals. Looking for private company due diligence data sources on Emalex Biosciences? Get in touch to learn more.
Similar Companies
like Emalex Biosciences
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Mind Robotics
AI & Machine Learning
Develops AI‑powered systems which handle complex manufacturing tasks with adaptable intelligence and physical autonomy.
Rubedo Life Sciences
Healthcare & Life Sciences
Discovers and develops medicines targeting pathologic cells to combat aging and age-related diseases using a proprietary drug discovery platform.
BrightInsight
Healthcare & Life Sciences
Provides a regulated digital health platform that captures, transmits, and analyzes data from connected medical devices.
Welcome to the Jungle
Media & Entertainment
Career platform connecting job seekers with employers through job listings, company culture insights, and professional resources.
Akston Biosciences
Healthcare & Life Sciences
Develops and manufactures protein-based therapeutics for pets using proprietary technology to create species-specific medical treatments.
Ursa Space Systems
Industrials
Converts satellite imagery into actionable insights for monitoring global physical changes and activity.
Block Mining Group
Web3 & Digital Assets
Operates large-scale Bitcoin mining facilities with energy-efficient infrastructure to support blockchain networks and cryptocurrency operations.
ArenaCX
Enterprise Software
Connects organizations with pre-vetted CX and BPO vendors, streamlining sourcing, contracting, and management for better business outcomes.
FAQ
We have answers
Emalex Biosciences stock does not trade on public stock exchanges. Emalex Biosciences stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Emalex Biosciences stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Emalex Biosciences Stock does not trade on public stock exchanges. In order to sell Emalex Biosciences shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Emalex Biosciences does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Emalex Biosciences share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Emalex Biosciences stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Emalex Biosciences stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Emalex Biosciences stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Emalex Biosciences is a private company and has not had an IPO. There is currently no Emalex Biosciences IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Emalex Biosciences IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
